Skip to main content
. 2017 Jul 9;5:24. doi: 10.1186/s40345-017-0093-5

Table 2.

Comparison of demographic data and clinical course between good responders and moderate/poor responders (N = 80)

Variables Good responders (N = 27) Moderate/poor responders (N = 53) Group difference
Statistics p value
Sex, male, N (%) 10 (37.0) 13 (24.5) χ 2 = 1.366 0.299
Age at study entry, years, mean (SD) 37.0 (9.1) 34.5 (7.3) t = −1.368 0.175
Age at onset, years, mean (SD)a 24.9 (8.7) 23.3 (6.3) t = −0.789 0.435
Duration of illness until using the index mood stabilizer, years, mean (SD) 6.07 (4.2) 5.42 (5.5) t = −0.551 0.583
Diagnosis, BD-I, N (%) 21 (77.8) 44 (83.0) χ 2 = 0.323 0.570
Index medication, N (%) FE 0.143
 Lithium 6 (22.2) 13 (24.5)
 Valproate 20 (74.1) 30 (56.6)
 Both lithium and valproate 1 (3.7) 10 (18.9)
Duration of index mood stabilizer treatment, months, mean (SD) 73.0 (36.4) 71.0 (33.1) t = −0.249 0.804
Polarity at the first episode, (hypo)manic, N (%) 13 (48.2) 28 (52.8) χ 2 = 0.157 0.692
Predominant polaritya χ 2 = 0.161 0.922
 Manic predominant 8 (32.0) 18 (35.3)
 Depressive predominant 5 (20.0) 11 (21.6)
 Undetermined 12 (48.0) 22 (43.1)
Number of episodes before using index mood stabilizer, mean (SD)
 Major depressive episodes 1.4 (1.1) 1.2 (1.3) t = −0.630 0.531
 Manic episodesb 1.3 (1.2) 0.9 (0.8) t = −1.284 0.207
 Hypomanicb 0.4 (0.8) 0.1 (0.3) t = −1.994 0.056
 Mixed episodesb 0.12 (0.3) 0.5 (1.2) t = 2.278 0.026
Family history of psychiatric disorders, N (%)c 16 (59.3) 32 (60.4) χ 2 = 0.009 0.923
Family history of mood disorders, N (%)d 8 (29.6) 20 (37.7) χ 2 = 0.517 0.472
Number of hospitalization before using index mood stabilizer treatment, mean (SD) 1.4 (1.2) 1.6 (1.2) t = 1.849 0.622
Current smoker, N (%) 5 (20.8) 8 (21.6) χ 2 = 0.005 0.941
CGI-BPe, severity of overall bipolar illness 1.6 (0.8) 3.2 (0.9) t = 7.876 0.000

BD-I bipolar I disorder, FE Fisher’s exact test, SD standard deviation

a N = 76

bEqual variance not assumed

cEvaluated in second-degree relatives

dEvaluated in second-degree relatives, including those with major depressive disorders and bipolar disorders

eClinical global impressions scale for use in bipolar illness